XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Investments and Fair Value Measurements
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Investments and Fair Value Measurements Investments and Fair Value Measurements
Investments
Investments in debt securities as of September 30, 2022 were as follows (in thousands):
As of September 30, 2022
Amortized CostGross Unrealized
Gains
Gross Unrealized LossesFair ValueCash EquivalentsShort-term Investments
Available-for-sale debt securities:
U.S. treasury securities$9,769 $— $(80)$9,689 $— $9,689 
U.S. government agency securities105,097 (281)104,819 80,317 24,502 
Commercial paper130,993 — (206)130,787 76,704 54,083 
Corporate debt securities116,876 — (1,522)115,354 5,842 109,512 
Total$362,735 $$(2,089)$360,649 $162,863 $197,786 
The Company did not hold any investments in debt securities as of December 31, 2021.
The fair value and amortized cost of the Company’s debt securities with a stated contractual maturity or redemption date were as follows (in thousands):
September 30, 2022
Amortized CostFair Value
Due in one year or less$255,526 $255,007 
Due in one year through five years107,209 105,642 
Total$362,735 $360,649 
As of September 30, 2022, investments in an unrealized loss position for which other-than-temporary impairments have not been recognized had an aggregate fair value of $320.3 million. None of these investments were in a continuous unrealized loss position for more than twelve months. The Company does not intend to sell these investments and it is not more likely than not that the Company will be required to sell these investments before recovery of their amortized cost basis. The Company anticipates that it will recover the entire amortized cost basis of these investments on or before maturity. During the three and nine months ended September 30, 2022, the Company did not recognize any other-than-temporary impairment losses on these securities.
Interest income from cash and cash equivalents and short-term investments was $0.5 million and $1.1 million for the three and nine months ended September 30, 2021, and $5.5 million and $7.9 million for the three and nine months ended September 30, 2022, respectively.
Fair Value Measurements
The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation (in thousands):
 As of September 30, 2022
 TotalLevel 1Level 2Level 3
Assets:    
Cash equivalents:    
Money market funds$640,978 $640,978 $— $— 
U.S. government agency securities80,317 — 80,317 — 
Commercial paper76,704 — 76,704 — 
Corporate debt securities5,842 — 5,842 — 
Total cash equivalents$803,841 $640,978 $162,863 $— 
Short-term investments:
U.S. treasury securities$9,689 $9,689 $— $— 
U.S. government agency securities24,502 — 24,502 — 
Commercial paper54,083 — 54,083 — 
Corporate debt securities109,512 — 109,512 — 
Total short-term investments$197,786 $9,689 $188,097 $— 
Total$1,001,627 $650,667 $350,960 $— 
 As of December 31, 2021
 TotalLevel 1Level 2Level 3
Assets:    
Cash equivalents:    
Money market funds$1,077,550 $1,077,550 $— $— 
Total$1,077,550 $1,077,550 $— $— 
Warrants Liability
In February and March 2021, TRATON Group (“TRATON”) and its subsidiary Navistar, Inc. (“Navistar”) exercised warrants to purchase 4,331,644 and 9,477,073 shares of Series E-2 and Series E redeemable convertible preferred stock at an exercise price of $11.31 and $14.14, resulting in proceeds of $49.0 million and $134.0 million, respectively. Immediately prior to their exercise, the fair value of the then existing warrants liability was remeasured using the Black-Scholes option-pricing model, resulting in a loss upon remeasurement of $326.9 million. The warrants exercised by TRATON represented only a portion of their total and the unexercised warrants expired as of the exercise date. As of September 30, 2022, there were no warrants outstanding.
The Company used the following assumptions in the model:
 As of
 
February 26,
2021
March 19,
2021
Fair value of underlying securities$40.00$40.00
Expected volatility62.95%60.85%
Expected term (in years)1.760.79
Risk-free interest rate0.14%0.08%